- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
Elite Pharmaceuticals Inc
+ Add to WatchlistELTP:US
0.0700 USD 0.00000.00%As of 17:20:00 ET on 05/22/2013.
Snapshot for Elite Pharmaceuticals Inc (ELTP)
| Open: | 0.0700 | Day's Range: | 0.0670 - 0.0700 | Volume: | 840,400 |
|---|---|---|---|---|---|
| Previous Close: | 0.0700 | 52wk Range: | 0.0507 - 0.1740 | 1-Yr Rtn: | -52.54% |
Key Statistics for ELTP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0400 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 24.36 |
| Shares Outstanding (M) | 356.72 |
| 30 Day Average Volume | 948,637 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 8.8183 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ELTP
Company Profile & Key Executives for ELTP
Elite Pharmaceuticals, Inc. researches, develops, licenses, and manufactures both new and generic oral controlled-release pharmaceutical products. The Company has pain products in clinical trials and has developed products incorporating therapeutic agents such as cardiovasculars, antidiabetic, cough and cold preparations, and anti-infectives.
| Jerry I TreppelChairman/CEO | Chris C DickConsultant |
| Carter J WardCFO/Secretary/Treasurer | Ashok G NigalayeChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ELTP News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page